"mesothelioma treatment" - Google News

U.S. News Names the Best Centers for Mesothelioma Care in 2026 - asbestos.com

2026-09-02T07:00:00.000000000Z

U.S. News Names the Best Centers for Mesothelioma Care in 2026 asbestos.com

Mesothelioma Diet and Nutrition Tips for Patients (2026) - Sokolove Law

2026-09-02T15:30:03.000000000Z

Mesothelioma Diet and Nutrition Tips for Patients (2026) Sokolove Law

What You Should Know About Mesothelioma in Younger Patients - Memorial Sloan Kettering Cancer Center

2026-03-31T07:00:00.000000000Z

What You Should Know About Mesothelioma in Younger Patients Memorial Sloan Kettering Cancer Center

Metastatic Malignant Mesothelioma of the Tunica Vaginalis Testis Treated With Sequential Immunotherapy, Chemotherapy, and Radiotherapy With Prolonged Disease Stabilisation: A Case Report - Cureus

2026-08-20T07:00:00.000000000Z

Metastatic Malignant Mesothelioma of the Tunica Vaginalis Testis Treated With Sequential Immunotherapy, Chemotherapy, and Radiotherapy With Prolonged Disease Stabilisation: A Case Report Cureus

A Long Shadow: Mapping Mesothelioma’s Uneven Decline Across the United States - University of Miami

2026-06-11T07:00:00.000000000Z

A Long Shadow: Mapping Mesothelioma’s Uneven Decline Across the United States University of Miami

On the horizon: proton beam therapy for mesothelioma - Hospital Healthcare Europe

2026-05-27T07:00:00.000000000Z

On the horizon: proton beam therapy for mesothelioma Hospital Healthcare Europe

Best Treatment for Mesothelioma in 2026? Combination of Surgery and Systemic - Mesothelioma Guide

2026-05-22T07:00:00.000000000Z

Best Treatment for Mesothelioma in 2026? Combination of Surgery and Systemic Mesothelioma Guide

Immunotherapy & Peritoneal Meso: 4 Key Facts for Patients - Mesothelioma.com

2026-06-24T07:00:00.000000000Z

Immunotherapy & Peritoneal Meso: 4 Key Facts for Patients Mesothelioma.com

Study reports a counterintuitive new approach to treating mesothelioma - News-Medical

2026-07-14T07:00:00.000000000Z

Study reports a counterintuitive new approach to treating mesothelioma News-Medical

How Artificial Intelligence Is Changing Mesothelioma Care - Mesothelioma.net

2026-07-28T07:00:00.000000000Z

How Artificial Intelligence Is Changing Mesothelioma Care Mesothelioma.net

Chemotherapy Remains Effective After Immunotherapy for Pleural Mesothelioma - mesotheliomahelp.org

2026-08-14T07:00:00.000000000Z

Chemotherapy Remains Effective After Immunotherapy for Pleural Mesothelioma mesotheliomahelp.org

Stanford Performs First PITAC Procedure for Mesothelioma in North America - Stanford Medicine

2026-06-11T07:00:00.000000000Z

Stanford Performs First PITAC Procedure for Mesothelioma in North America Stanford Medicine

Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview - Wiley Online Library

2026-04-23T07:00:00.000000000Z

Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview Wiley Online Library

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study - The Lancet

2026-06-17T07:00:00.000000000Z

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study The Lancet

MSK Research Highlights, June 11, 2026 - Memorial Sloan Kettering Cancer Center

2026-06-11T07:00:00.000000000Z

MSK Research Highlights, June 11, 2026 Memorial Sloan Kettering Cancer Center

Top Mesothelioma Cancer Centers U.S. News & World Report 2026-2027 - Mesothelioma Guide

2026-08-13T10:20:47.000000000Z

Top Mesothelioma Cancer Centers U.S. News & World Report 2026-2027 Mesothelioma Guide

Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients - University of Miami

2026-05-05T07:00:00.000000000Z

Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients University of Miami

Yearly Recap: 2025 Mesothelioma Research Advances - Mesothelioma.com

2026-01-14T08:00:00.000000000Z

Yearly Recap: 2025 Mesothelioma Research Advances Mesothelioma.com

AI Performance in Measuring Mesothelioma Tumors Will Transform Treatment Decisions - Mesothelioma.net

2026-06-18T07:00:00.000000000Z

AI Performance in Measuring Mesothelioma Tumors Will Transform Treatment Decisions Mesothelioma.net

Mesothelioma Treatment Receives Second Orphan Drug Designation - Mesothelioma.net

2026-06-23T07:00:00.000000000Z

Mesothelioma Treatment Receives Second Orphan Drug Designation Mesothelioma.net

FDA Grants Orphan Drug Designation to Mesothelioma Treatment - Mesothelioma.net

2026-04-21T07:00:00.000000000Z

FDA Grants Orphan Drug Designation to Mesothelioma Treatment Mesothelioma.net

Case Study Shows Nivolumab Monotherapy Promising for Pleural Mesothelioma - Mesothelioma Guide

2026-06-12T07:00:00.000000000Z

Case Study Shows Nivolumab Monotherapy Promising for Pleural Mesothelioma Mesothelioma Guide

AI accurately measures mesothelioma tumors for better treatment decisions - News-Medical

2026-06-17T07:00:00.000000000Z

AI accurately measures mesothelioma tumors for better treatment decisions News-Medical

Insilico Medicine to Present AI-Designed Drug for Mesothelioma Treatment, FDA to Fast-Track - Mesothelioma Guide

2026-07-30T07:00:00.000000000Z

Insilico Medicine to Present AI-Designed Drug for Mesothelioma Treatment, FDA to Fast-Track Mesothelioma Guide

Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma - Frontiers

2026-05-29T14:24:08.000000000Z

Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma Frontiers

Pleurectomy Decortication Safe in Select Patients With Pleural Mesothelioma - ascopost.com

2026-02-18T08:00:00.000000000Z

Pleurectomy Decortication Safe in Select Patients With Pleural Mesothelioma ascopost.com

AI-Based Pan-TEAD Inhibitor Wins FDA Fast Track Designation in Mesothelioma - CancerNetwork

2026-07-29T07:00:00.000000000Z

AI-Based Pan-TEAD Inhibitor Wins FDA Fast Track Designation in Mesothelioma CancerNetwork

New Mesothelioma Drug Controls Disease in Early Trial - asbestos.com

2026-07-20T07:00:00.000000000Z

New Mesothelioma Drug Controls Disease in Early Trial asbestos.com

Proton beam trial hope for asbestos cancer patients - BBC

2026-03-11T07:00:00.000000000Z

Proton beam trial hope for asbestos cancer patients BBC

Metabolic vulnerabilities in pleural mesothelioma - Nature

2026-05-20T07:00:00.000000000Z

Metabolic vulnerabilities in pleural mesothelioma Nature

CAR T-Cell Therapy for Mesothelioma - Mesothelioma Guide

2026-08-11T07:00:00.000000000Z

CAR T-Cell Therapy for Mesothelioma Mesothelioma Guide

Mesothelioma Hope Interviews MD Anderson Oncologist Dr. Kanwal Raghav on Immunotherapy Advances and the Future of Peritoneal Mesothelioma Treatment - Times Argus

2026-08-25T14:01:23.000000000Z

Mesothelioma Hope Interviews MD Anderson Oncologist Dr. Kanwal Raghav on Immunotherapy Advances and the Future of Peritoneal Mesothelioma Treatment Times Argus

How Mesothelioma Treatment Can Differ From One Patient to Another - BNO News

2026-08-26T03:11:10.000000000Z

How Mesothelioma Treatment Can Differ From One Patient to Another BNO News

Mount Sinai Study Strengthens Landmark Evidence Supporting Lung-Sparing Surgery, Offering Hope for Mesothelioma Patients - Mount Sinai

2026-02-12T14:58:40.000000000Z

Mount Sinai Study Strengthens Landmark Evidence Supporting Lung-Sparing Surgery, Offering Hope for Mesothelioma Patients Mount Sinai

Will New Tumor Injection Be a Breakthrough for Mesothelioma Patients? - Mesothelioma.net

2026-06-16T07:00:00.000000000Z

Will New Tumor Injection Be a Breakthrough for Mesothelioma Patients? Mesothelioma.net

Webinar Recap: Surgery for Peritoneal Mesothelioma - asbestos.com

2026-05-04T07:00:00.000000000Z

Webinar Recap: Surgery for Peritoneal Mesothelioma asbestos.com

Scientists Discover Drug Combination That Targets BAP1-Deficient Mesothelioma - Mesothelioma.net

2026-04-06T07:00:00.000000000Z

Scientists Discover Drug Combination That Targets BAP1-Deficient Mesothelioma Mesothelioma.net

New KIR-CAR T cell therapy shows promise in solid cancers - Penn Medicine

2026-04-20T07:00:00.000000000Z

New KIR-CAR T cell therapy shows promise in solid cancers Penn Medicine

To What Extent Does Fibrosis Act as a Limiting Factor for Surgery in Pleural Mesothelioma Following Neoadjuvant Therapy? - ASCO Daily News

2026-06-19T05:06:37.000000000Z

To What Extent Does Fibrosis Act as a Limiting Factor for Surgery in Pleural Mesothelioma Following Neoadjuvant Therapy? ASCO Daily News

Proton Beam Therapy Trial Offers Hope for Better Mesothelioma Survival Outcomes - Mesothelioma.net

2026-03-12T07:00:00.000000000Z

Proton Beam Therapy Trial Offers Hope for Better Mesothelioma Survival Outcomes Mesothelioma.net

Stanford Surgeons Perform First PITAC Procedure for Pleural Mesothelioma - Mesothelioma Guide

2026-06-22T07:00:00.000000000Z

Stanford Surgeons Perform First PITAC Procedure for Pleural Mesothelioma Mesothelioma Guide

Mesothelioma in Younger Patients: Doctors Want to Know Why - asbestos.com

2026-04-20T07:00:00.000000000Z

Mesothelioma in Younger Patients: Doctors Want to Know Why asbestos.com

New mesothelioma treatment turns cancer’s defense into its weakness - The Brighter Side of News

2026-07-27T07:00:00.000000000Z

New mesothelioma treatment turns cancer’s defense into its weakness The Brighter Side of News

Can AI Treat Mesothelioma? AI Cancer Detection 2026 - Sokolove Law

2026-02-24T08:00:00.000000000Z

Can AI Treat Mesothelioma? AI Cancer Detection 2026 Sokolove Law

Conditional survival patterns and individualized prognostic prediction in malignant peritoneal mesothelioma - Nature

2026-06-01T07:00:00.000000000Z

Conditional survival patterns and individualized prognostic prediction in malignant peritoneal mesothelioma Nature

New Study Probes Immunotherapy Before and After Mesothelioma Surgery - Mesothelioma Guide

2026-08-04T07:00:00.000000000Z

New Study Probes Immunotherapy Before and After Mesothelioma Surgery Mesothelioma Guide

FDA Grants Fast Tract Designation to VT3989 for Mesothelioma - Cure Today

2025-10-09T07:00:00.000000000Z

FDA Grants Fast Tract Designation to VT3989 for Mesothelioma Cure Today

PRX3 Inhibitor Produces Promising Results in Pleural Mesothelioma - Mesothelioma Guide

2026-07-17T07:00:00.000000000Z

PRX3 Inhibitor Produces Promising Results in Pleural Mesothelioma Mesothelioma Guide

Proposed Peritoneal Mesothelioma Staging Could Fill Critical Gap - asbestos.com

2026-02-12T08:00:00.000000000Z

Proposed Peritoneal Mesothelioma Staging Could Fill Critical Gap asbestos.com

Global Forum to Bring Together International Mesothelioma Experts - Mesothelioma.net

2026-07-01T07:00:00.000000000Z

Global Forum to Bring Together International Mesothelioma Experts Mesothelioma.net

Phase 2 CHIMERA Trial Tests Neoadjuvant Pembrolizumab in Mesothelioma - Targeted Oncology

2026-07-27T07:00:00.000000000Z

Phase 2 CHIMERA Trial Tests Neoadjuvant Pembrolizumab in Mesothelioma Targeted Oncology

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models - Nature

2026-02-11T08:00:00.000000000Z

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models Nature

Haemophagocytic Lymphohistiocytosis Following Ipilimumab and Nivolumab in Malignant Pleural Mesothelioma: A Case Report - Cureus

2026-07-16T07:00:00.000000000Z

Haemophagocytic Lymphohistiocytosis Following Ipilimumab and Nivolumab in Malignant Pleural Mesothelioma: A Case Report Cureus

Innovative New Technique Destroys 99% of Cancer Cells, Offering Hope for Mesothelioma - Mesothelioma.net

2026-07-20T07:00:00.000000000Z

Innovative New Technique Destroys 99% of Cancer Cells, Offering Hope for Mesothelioma Mesothelioma.net

Immunotherapy Timing | Do AM Infusions Boost Survival? - Mesothelioma.com

2026-03-18T07:00:00.000000000Z

Immunotherapy Timing | Do AM Infusions Boost Survival? Mesothelioma.com

AI-Assisted Tumor Volume Response Criteria Outperform Physician Assessments and RECIST Criteria in Pleural Mesothelioma - ascopost.com

2026-06-19T07:00:00.000000000Z

AI-Assisted Tumor Volume Response Criteria Outperform Physician Assessments and RECIST Criteria in Pleural Mesothelioma ascopost.com

Mesothelioma Drug Development Targeting HIPPO Pathway Proves Challenging - Mesothelioma.net

2026-01-20T08:00:00.000000000Z

Mesothelioma Drug Development Targeting HIPPO Pathway Proves Challenging Mesothelioma.net

Study Shows Immune Cell Clusters Predict Which Mesothelioma Patients Will Live Longer - Mesothelioma.net

2026-04-30T07:00:00.000000000Z

Study Shows Immune Cell Clusters Predict Which Mesothelioma Patients Will Live Longer Mesothelioma.net

Should Surgery Be Performed for Sarcomatoid Mesothelioma? - mesotheliomahelp.org

2026-06-03T07:00:00.000000000Z

Should Surgery Be Performed for Sarcomatoid Mesothelioma? mesotheliomahelp.org

Five-Year Study Confirms Lasting Benefits of Immunotherapy for Mesothelioma - mesotheliomahelp.org

2026-03-11T07:00:00.000000000Z

Five-Year Study Confirms Lasting Benefits of Immunotherapy for Mesothelioma mesotheliomahelp.org

New Facebook Support Group Offers Expert Guidance and Community for People Living with Mesothelioma - mesotheliomahelp.org

2026-08-14T07:00:00.000000000Z

New Facebook Support Group Offers Expert Guidance and Community for People Living with Mesothelioma mesotheliomahelp.org

AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit - EurekAlert!

2026-06-17T07:00:00.000000000Z

AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit EurekAlert!

KIR-CAR: a multichain CAR-T model advancing solid tumor treatment - RegMedNet

2026-04-22T07:00:00.000000000Z

KIR-CAR: a multichain CAR-T model advancing solid tumor treatment RegMedNet

Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship - Cure Today

2025-11-02T07:00:00.000000000Z

Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship Cure Today

Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission - Yahoo Finance

2026-06-22T07:00:00.000000000Z

Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission Yahoo Finance

Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report - Cureus

2026-06-01T07:00:00.000000000Z

Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report Cureus

Immunotherapy Study Shows 22% Improved Survival in Mesothelioma - Mesothelioma.net

2025-12-24T08:00:00.000000000Z

Immunotherapy Study Shows 22% Improved Survival in Mesothelioma Mesothelioma.net

Case Report: Clinical course and extended survival in a canine patient with pericardial mesothelioma managed without chemotherapeutic intervention - Frontiers

2026-04-30T19:13:23.000000000Z

Case Report: Clinical course and extended survival in a canine patient with pericardial mesothelioma managed without chemotherapeutic intervention Frontiers

Clinical Trial Shows Promising Results for CAR T-cell Therapy in Advanced Mesothelioma - Mesothelioma Guide

2026-08-17T15:27:10.000000000Z

Clinical Trial Shows Promising Results for CAR T-cell Therapy in Advanced Mesothelioma Mesothelioma Guide

2026 Mesothelioma.com Scholarship Winner | Madison Hager - Mesothelioma.com

2026-06-17T07:00:00.000000000Z

2026 Mesothelioma.com Scholarship Winner | Madison Hager Mesothelioma.com

Dr. Jeffrey Velotta on Surgery and Treatment - mesotheliomahelp.org

2026-05-29T07:00:00.000000000Z

Dr. Jeffrey Velotta on Surgery and Treatment mesotheliomahelp.org

UVM finds new drug to fight lung cancer could be a game changer - WCAX

2026-07-14T07:00:00.000000000Z

UVM finds new drug to fight lung cancer could be a game changer WCAX

Veterans and Mesothelioma: Understanding VA Benefits & Legal Options - Cohen, Placitella & Roth, P.C.

2026-04-03T07:00:00.000000000Z

Veterans and Mesothelioma: Understanding VA Benefits & Legal Options Cohen, Placitella & Roth, P.C.

Finding the right target: Personalizing treatment for an aggressive asbestos-linked cancer - EurekAlert!

2026-06-17T07:00:00.000000000Z

Finding the right target: Personalizing treatment for an aggressive asbestos-linked cancer EurekAlert!

First-Line Nivolumab Plus Ipilimumab in Inoperable Epithelioid Malignant Pleural Mesothelioma: Real-World Experience From an Indian Tertiary Care Center - Cureus

2026-07-24T07:00:00.000000000Z

First-Line Nivolumab Plus Ipilimumab in Inoperable Epithelioid Malignant Pleural Mesothelioma: Real-World Experience From an Indian Tertiary Care Center Cureus

Mesothelioma Statistics 2026 | Cases & Death Rates - Sokolove Law

2026-08-01T07:00:00.000000000Z

Mesothelioma Statistics 2026 | Cases & Death Rates Sokolove Law

Isolated primary pericardial sarcomatoid mesothelioma: a case report - Frontiers

2026-03-19T20:17:47.000000000Z

Isolated primary pericardial sarcomatoid mesothelioma: a case report Frontiers

FDA Grants Fast Track Designation to VT3989 for Unresectable Mesothelioma - OncLive

2025-10-08T07:00:00.000000000Z

FDA Grants Fast Track Designation to VT3989 for Unresectable Mesothelioma OncLive

Second-Line Pembrolizumab Plus Lenvatinib in Pleural Mesothelioma - ascopost.com

2025-12-03T08:00:00.000000000Z

Second-Line Pembrolizumab Plus Lenvatinib in Pleural Mesothelioma ascopost.com

Carrie B. Lee, MD, MPH - Mesothelioma.net

2026-06-09T07:00:00.000000000Z

Carrie B. Lee, MD, MPH Mesothelioma.net

Malignant mesothelioma in rare sites: two case reports - Frontiers

2025-11-13T00:15:31.000000000Z

Malignant mesothelioma in rare sites: two case reports Frontiers

Mesothelioma: reviewing the therapy pipeline - Oncology Central

2026-01-27T08:00:00.000000000Z

Mesothelioma: reviewing the therapy pipeline Oncology Central

RETRACTED ARTICLE: A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing - Nature

2025-11-21T08:00:00.000000000Z

RETRACTED ARTICLE: A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing Nature

Analyzing Age and Survival for Mesothelioma - Mesothelioma Guide

2026-03-30T07:00:00.000000000Z

Analyzing Age and Survival for Mesothelioma Mesothelioma Guide

ARTIMES AI Volumetry May Improve Response Assessment in Pleural Mesothelioma - Oncodaily

2026-06-19T07:00:00.000000000Z

ARTIMES AI Volumetry May Improve Response Assessment in Pleural Mesothelioma Oncodaily

Renowned Mesothelioma Nurse Specialist Joins Belluck Law - mesotheliomahelp.org

2026-04-09T07:00:00.000000000Z

Renowned Mesothelioma Nurse Specialist Joins Belluck Law mesotheliomahelp.org

Orion Pharma’s ODM-212 Granted Orphan Designation for the - GlobeNewswire

2026-06-23T07:00:00.000000000Z

Orion Pharma’s ODM-212 Granted Orphan Designation for the GlobeNewswire

Finding the right target: Personalising treatment for an aggressive asbestos-linked cancer - University of Leicester

2026-06-17T07:00:00.000000000Z

Finding the right target: Personalising treatment for an aggressive asbestos-linked cancer University of Leicester

Lung Leavin’ Day: 20 Years of Smashing Fears & Celebrating Life - Mesothelioma.com

2026-01-22T08:00:00.000000000Z

Lung Leavin’ Day: 20 Years of Smashing Fears & Celebrating Life Mesothelioma.com

How Flexible Work Helps Cancer Patients Balance Treatment and Recovery - asbestos.com

2025-10-29T12:20:26.000000000Z

How Flexible Work Helps Cancer Patients Balance Treatment and Recovery asbestos.com

The Mesothelioma Journey Part 3: Diagnosis from Exposure - Mesothelioma Hub

2026-02-12T08:00:00.000000000Z

The Mesothelioma Journey Part 3: Diagnosis from Exposure Mesothelioma Hub

Paul Kraus, Mesothelioma Survivor - Mesothelioma Guide

2026-03-31T07:00:00.000000000Z

Paul Kraus, Mesothelioma Survivor Mesothelioma Guide

Opdivo-Yervoy Tops Chemotherapy in Mesothelioma Survival - Mesothelioma Guide

2026-03-06T08:00:00.000000000Z

Opdivo-Yervoy Tops Chemotherapy in Mesothelioma Survival Mesothelioma Guide

Mount Sinai study strengthens landmark evidence supporting lung-sparing surgery, offering hope for mesothelioma patients - EurekAlert!

2026-02-12T08:00:00.000000000Z

Mount Sinai study strengthens landmark evidence supporting lung-sparing surgery, offering hope for mesothelioma patients EurekAlert!

Beyond the Buzz: Tumor Treating Fields for Cancer - Medscape

2025-12-01T08:00:00.000000000Z

Beyond the Buzz: Tumor Treating Fields for Cancer Medscape

Dipesh Uprety, MD - Mesothelioma.net

2026-06-18T07:00:00.000000000Z

Dipesh Uprety, MD Mesothelioma.net

Mesothelioma Vaccines | Mesothelioma Treatment & Prevention - Mesothelioma.net

2025-10-13T07:00:00.000000000Z

Mesothelioma Vaccines | Mesothelioma Treatment & Prevention Mesothelioma.net

New Study Says Pleurectomy/Decortication Safe - Mesothelioma Guide

2026-02-24T08:00:00.000000000Z

New Study Says Pleurectomy/Decortication Safe Mesothelioma Guide

Benjamin Herzberg, MD - Mesothelioma.net

2026-06-11T07:00:00.000000000Z

Benjamin Herzberg, MD Mesothelioma.net

Miguel F. Alvelo-Rivera, MD - Mesothelioma.net

2026-05-06T07:00:00.000000000Z

Miguel F. Alvelo-Rivera, MD Mesothelioma.net